Lifeward Ltd. completed its acquisition of Oratech Ltd. on 2026-03-25, according to the Form 8-K Lifeward Ltd. filed with the SEC on 2026-03-25. The filing's Item 2.01 states no aggregate dollar price.
| Acquirer | Lifeward Ltd. |
|---|---|
| Acquired | Oratech Ltd. |
| Completed | 2026-03-25 |
| Reported by | Lifeward Ltd. (LFWD), the buyer |
| Filing | Form 8-K, filed 2026-03-25 |
Want the whole picture on Lifeward Ltd.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Lifeward Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Lifeward Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What the filing says
On March 25, 2026, the Company completed its acquisition of Oratech in accordance with the terms of the Share Purchase Agreement.
More from the filing
As previously disclosed on January 12, 2026, Lifeward Ltd. (the "Company") entered into a Share Purchase Agreement ("Share Purchase Agreement") with Oramed Pharmaceuticals, Inc. ("Oramed") and Oratech Pharma, Inc. ("Oratech Pharma"), pursuant to which the Company agreed to acquire all of the outstanding equity interests in Oratech Pharma, a wholly-owned subsidiary of Oramed (the "Oratech Share Purchase").
At the closing of the Oratech Share Purchase, the Company issued an aggregate 2,256,476 shares of its ordinary shares (the "Ordinary Shares") and pre-funded warrants to purchase Ordinary Shares (the "Pre-Funded Warrants").
As additional consideration to Oramed, the Company also issued 1,296,296 warrants to purchase Ordinary Shares (the "Transaction Warrants") and has agreed to pay Oramed certain quarterly revenue sharing payments based on sales of the Company's ReWalk Personal Exoskeleton products and related extended warranties.
Quoted from Lifeward Ltd.'s Form 8-K.
This is the only completed acquisition Lifeward Ltd. reported under Item 2.01 in the last twelve months.
Lifeward Ltd.'s funding history
Who runs it now, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on Lifeward Ltd.Look up Lifeward Ltd. and see what is on record before you decide.
Get the free SnapshotWhere this comes from
A public company must file a current report on Form 8-K with the SEC within four business days of completing a significant acquisition or disposition of assets, under Item 2.01 of the report. The acquired company sometimes files one too, when the deal makes it a subsidiary of the buyer.
Every fact on this page is taken from one of those filings and linked to it: which company acquired which, the date the filing gives for completion, and the price when the filing states one in dollars, shown next to the sentence that states it. A filing states what was bought and on what terms; it rarely states why, and neither does this page.